C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2002
08/22/2002	US20020115189 Generating genetically engineered, adeno-associated virons: obtain cells, transform with viral vector, express vector, recover transformed cells, culture cells and recover virons
08/22/2002	US20020115187 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of arthritis and cancer; for use as antiscarring agent
08/22/2002	US20020115186 Peptide for use in the diagnosis, prevention, and treatment of inflammation, cancer, arteriosclerosis and degenerative defects
08/22/2002	US20020115183 Enzymatic protien for us ein prevention of tumor metastasis
08/22/2002	US20020115176 Polypeptide for use in the diagnosis and treatment of asthma, and respiratory disorders
08/22/2002	US20020115167 Isolation of drosophila and human polynucleotides encoding PAR-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides
08/22/2002	US20020115166 Peptide for use in the treatment of pancreatic defects
08/22/2002	US20020115165 Prevascularzed polymeric implants for organ transplantation
08/22/2002	US20020115157 Intrinsically fluorescent, self-multimerizing MHC fusion proteins and complexes thereof
08/22/2002	US20020115156 Connective tissue growth factor for use in the treatment of cancer, fibrotic defects and atherosclerosis; for use as wound healing agents
08/22/2002	US20020115155 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of eating disorders
08/22/2002	US20020115154 Trail receptors, nucleic acids encoding the same, and methods of use thereof
08/22/2002	US20020115152 Expression system for factor VIII
08/22/2002	US20020115151 Human defensin polypeptide Def-X, genomic DNA and cDNA, composition containing them and applications to diagnosis and to therapeutic treatment
08/22/2002	US20020115145 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/22/2002	US20020115140 Nucleotide sequences coding preferential polypeptide for use in treatment of immmunological defects
08/22/2002	US20020115138 Nucleotide sequences coding transport protein for use in treat ment of tumors
08/22/2002	US20020115135 Synapse related glycoproteins
08/22/2002	US20020115120 Controlling polypetide activity in cell; obtain cell, incubate with modulator, monitor gene expression and protein activity
08/22/2002	US20020115113 Conductive polymer matrix for use in the efficient isolation of preferential stem cells
08/22/2002	US20020115110 Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2
08/22/2002	US20020115086 Diagnosing allergic dermatitis in humans; obtain cells, extract nucleotide sequence, incubate with probes, measure concentration of preferential interleukin, ampified concentrations of interleukins in skin indicates allergic
08/22/2002	US20020115081 Nucleotide sequences coding polypeptide for use in the the treatament of cardiovasculAR disorders
08/22/2002	US20020115059 Drug screening system
08/22/2002	US20020114816 Autoreactive peptides from human glutamic acid-decarboxylase (gad)
08/22/2002	US20020114812 Preparing cells as cancer therapy for administration to a subject with cancer comprising culturing cells in the presence of an macrophage migration inhibitory factor antagonist
08/22/2002	US20020114797 Composition and methods for modulating the length of telomeres
08/22/2002	US20020114793 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
08/22/2002	US20020114791 Dehydration; freeze-drying; removing alcohol (sterol or cholesterol); loading with oligosaccharides to preserve; storage stability
08/22/2002	US20020114789 Methods of controlling proliferation and differentiation of stem and progenitor cells
08/22/2002	US20020114781 Interleukin antagonists for suppressing autoimmune respone via reducing number of antigen-reactive lymphocytes; treatment of rheumatic diseases
08/22/2002	US20020114772 Methods of modulating hair growth
08/22/2002	DE10104584A1 Medane-Gene und- Proteine Medane genes and- proteins
08/22/2002	CA2856986A1 Post-partum mammalian placenta, its use and placental stem cells therefrom
08/22/2002	CA2443266A1 A bi-directional dual promoter complex with enhanced promoter activity for transgene expression in eukaryotes
08/22/2002	CA2440743A1 Matrix gene expression in chondrogenesis
08/22/2002	CA2438658A1 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
08/22/2002	CA2438501A1 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/22/2002	CA2438219A1 Sequences involved in phenomena of tumour suppression, tumour reversion apoptosis and/or virus resistance and their use as medicines
08/22/2002	CA2438215A1 Putative human enzymes
08/22/2002	CA2438153A1 Post-partum mammalian placenta, its use and placental stem cells therefrom
08/22/2002	CA2438125A1 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof
08/22/2002	CA2437957A1 Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
08/22/2002	CA2437873A1 Neurotonin and use thereof
08/22/2002	CA2437811A1 Human g-protein chemokine receptor (ccr5) hdgnr10
08/22/2002	CA2437799A1 Fusion proteins based upon somatostatin receptors
08/22/2002	CA2437576A1 Method for evaluating therapeutic efficacy
08/22/2002	CA2437246A1 Novel human poly(a)polymerase gamma (pap gamma)
08/22/2002	CA2436713A1 Proteins and nucleic acids encoding same
08/22/2002	CA2436259A1 Compounds effecting neuron remodeling and assays for same
08/22/2002	CA2433843A1 Molecules for disease detection and treatment
08/22/2002	CA2433079A1 Regulatory genes suitable for use in gene expression
08/22/2002	CA2432111A1 Jfy1 protein induces rapid apoptosis
08/22/2002	CA2430726A1 Isolated human transporter proteins, nucleic acid molecules encoding them and uses thereof
08/22/2002	CA2427112A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
08/21/2002	EP1233074A1 Vegf responsive cell-based assay for determining vegf bioactivity
08/21/2002	EP1233063A2 Transgenic animals containing a dominant negative mutant form of the p85 subunit of pi-3 kinase
08/21/2002	EP1233059A1 Influenza viruses with enhanced transcriptional and replicational capacities
08/21/2002	EP1233058A1 Method of proliferating natural killer cells
08/21/2002	EP1233026A1 Antibody against rat postacrosome reaction sperm and utilization thereof
08/21/2002	EP1233023A1 Transcription factor and dna thereof
08/21/2002	EP1232396A2 Assay of isomerised and/or optically inverted proteins
08/21/2002	EP1232394A1 Sandwich immunoassay and monoclonal antibodies for comp, cartillage oligomeric matrix protein
08/21/2002	EP1232273A2 Chemical inducible promoters used to obtain transgenic plants with a silent marker
08/21/2002	EP1232268A2 Cytochrome p450 oxygenases and their uses
08/21/2002	EP1232267A2 Activation of hcv-specific t cells
08/21/2002	EP1232266A2 Polypeptides and nucleic acids encoding same
08/21/2002	EP1232265A2 G-protein coupled receptor htogh35
08/21/2002	EP1232264A2 Human fgf-21 gene and gene expression products
08/21/2002	EP1232263A2 Polypeptides and nucleic acids encoding same
08/21/2002	EP1232262A2 Recombinant gelatin in vaccines
08/21/2002	EP1232261A2 Cloning and characterization of the cap gene promoter
08/21/2002	EP1232260A2 Polymorphisms in the human mdr-1 gene and applications thereof
08/21/2002	EP1232250A2 Oleoyl-acyl-carrier-protein thioesterases in plants
08/21/2002	EP1232249A1 Duck pneumovirus and corresponding vaccines
08/21/2002	EP1232248A1 Recombinant eggs and gene cloning and expression vectors based on avian adenoviruses
08/21/2002	EP1232247A2 Modulation of signal transduction
08/21/2002	EP1232246A1 A human normal counterpart of cd4+ cd56+ cutaneous neoplasm
08/21/2002	EP1232203A1 3d matrix for producing cell transplants
08/21/2002	EP1232182A2 Animal collagens and gelatins
08/21/2002	EP1232181A2 Recombinant gelatins
08/21/2002	EP1232180A1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues
08/21/2002	EP1232179A1 15 human secreted proteins
08/21/2002	EP1232178A2 Compositions and methods for regulating tumor-associated antigen expression
08/21/2002	EP1232175A2 Method of forming a peptide-receptor complex with zsig33 and therapeutic use thereof
08/21/2002	EP1232174A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals
08/21/2002	EP1232170A1 Antimitotic compounds
08/21/2002	EP1231947A2 Injectable bone-substitute material
08/21/2002	EP1231943A1 Interferon gamma conjugates
08/21/2002	EP1231937A2 Tr3-specific binding agents and methods for their use
08/21/2002	EP1231934A2 Methods of inhibiting atrophy or promoting hypertrophy
08/21/2002	EP1231930A1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS
08/21/2002	EP1231840A1 Anti-angiogenic cellular agent for cancer therapy
08/21/2002	EP1231837A2 Preservation of sensitive biological material
08/21/2002	EP1231836A2 Human ex vivo immune system
08/21/2002	EP1231835A2 Flowering time modification
08/21/2002	EP1231831A1 Stress-resistant oversized transgenic plants capable of growing in salinized soil
08/21/2002	EP1154801A4 Integration of transplanted neural progenitor cells into neural tissue of immature and mature dystrophic recipients
08/21/2002	EP0983075B1 A method to increase the survival of transplanted cells
08/21/2002	EP0642580B1 Hepatocyte growth factor variants

1 ... 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 ... 1827